Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 4Unspecified Childhood Solid Tumor, Protocol Specific 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Breast Neoplasms, Male 1

Interventions

sargramostim 1etoposide phosphate 1Methylprednisolone 1Melphalan 1Mass Spectrometry 1Immunologic Techniques 1Genetic Testing 1Gene Expression Profiling 1Flow Cytometry 1Cyclosporine 1Cyclophosphamide 1Cord Blood Stem Cell Transplantation 1Carboplatin 1Busulfan 1Antilymphocyte Serum 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Unspecified Childhood Solid Tumor, Protocol Specific × Immunologic Techniques × Clear all
NCT00436761 2013-12-18

Busulfan, Melphalan, and Antithymocyte Globulin Followed By Umbilical Cord Blood Transplant in Treating Young Patients With Refractory or Relapsed Malignant Solid Tumors

National Cancer Institute (NCI)

Phase 1 Unknown
20 enrolled
Other solid neoplasm

Unspecified Childhood Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡